Results 71 to 80 of about 10,287 (203)

Lactucin & Lactucopicrin ameliorates FFA-induced steatosis in HepG2 cells via modulating lipid metabolism

open access: yesJournal of Pharmacological Sciences, 2022
Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases, and there are no effective drugs available so far. Lactucin and Lactucopicrin belong to sesquiterpene lactones and are extracted from Cichorium glandulosum Boiss.
Yilizere Aibaidula   +5 more
doaj  

Systemic retinoids for treatment of recalcitrant IgA pemphigus

open access: yesOrphanet Journal of Rare Diseases, 2018
IgA pemphigus is an exceedingly rare autoimmune blistering disorder, caused by IgA autoantibodies against desmosomal proteins. No treatment option has been found to be universally effective.
Franziska Schauer   +2 more
doaj   +1 more source

Mechanisms of Low Density Lipoprotein Lowering by Hypolipidemic Agents

open access: yesAnnals of Medicine, 1991
Most hypolipidemic agents have been developed to reduce to normal high plasma concentrations of low density lipoprotein (LDL), the most atherogenic substance in human plasma. Various agents work with many different mechanisms, some of which are not understood. Mechanistic studies are helpful--e.g., for understanding of the various effects of treatment,
openaire   +3 more sources

Effect of Probiotic Therapy on Clinical-Biochemical and Instrumental Parameters of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2014
We examined 72 patients with type 2 diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). According to course of therapy all patients were divided into two groups.
G.P. Mykhalchyshyn   +2 more
doaj   +1 more source

Are We Using Ezetimibe As Much As We Should?

open access: yesBiomarker Insights
Lipid-lowering therapies, particularly non-statin regimens, are underutilized as ~2/3 of patients with atherosclerotic cardiovascular (CV) disease (CVD) are not optimally managed, and do not attain target low-density lipoprotein cholesterol (LDL-C ...
Antonis A Manolis   +3 more
doaj   +1 more source

Hypolipidemic effect of Silymarin in Dyslipidaemia of Different Etiologies

open access: yesمجلة كلية الطب, 2008
Background: Many drug and non drug approaches are utilized for the treatment of dyslipidemia; flavonoids, the major constituents of silymarin, have been proved to positively modify lipoproteins in experimentally – induced dyslipidemia.
Bahir Abdul Razzaq Mesheimish   +4 more
doaj  

Gastric Morphological Changes Including Carcinoid Tumors in Animals Treated with a Potent Hypolipidemic Agent, Ciprofibrate [PDF]

open access: bronze, 1989
Andrew J. Spencer   +5 more
openalex   +1 more source

Identification of Bioactive Agents and Immunomodulatory Factors from Seashells of the Persian Gulf

open access: yesIranian South Medical Journal, 2010
Background: Research in marine pharmacology will promise new bioactive agents. The marine bioenvironment is the unique resource for bioactive agents that could not be found in terrestrial organisms.
Arezoo Najafi   +3 more
doaj  

Successful management of a pregnancy women with sudden onset of acute pancreatitis: A case report and literature review

open access: yesTaiwanese Journal of Obstetrics & Gynecology
Objective: Hypertriglyceridemia (HTG) is a rare cause of acute pancreatitis (AP) in pregnancies and has emerged as an aggravating factor of severe pancreatitis. To enhance the diagnosis and management of HTG-induced AP during pregnancy by improving early
Yi-Er Huang, Chih-Yi Yang
doaj  

Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review

open access: yesJournal of Ophthalmology, 2018
Diabetic retinopathy (DR) is classically defined by its vascular lesions and damage in the neurons of the retina. The cellular and clinical elements of DR have many features of chronic inflammation. Understanding the individual cell-specific inflammatory
Lei Lu   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy